Surrogate endpoints in breast cancer screening trials - Authors' reply

Lancet Oncol. 2022 Aug;23(8):e361. doi: 10.1016/S1470-2045(22)00396-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Breast Neoplasms* / diagnosis
  • Disease-Free Survival
  • Early Detection of Cancer*
  • Female
  • Humans

Substances

  • Biomarkers